Managing adverse events associated with chemotherapy and immunotherapy for follicular lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing adverse events associated with chemotherapy and immunotherapy for follicular lymphoma

Published:2012-11 Issue:11 Volume:9 Page:S68-S76
ISSN:1548-5315
Container-title:Community Oncology
language:en
Short-container-title:Community Oncology

Author:

Waldman Anne Robin

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference54 articles.

1. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?;McLaughlin;Clin Lymphoma Myeloma Leuk,2011

2. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy;Richardson;J Clin Oncol,1988

3. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up;Czuczman;J Clin Oncol,2004

4. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

5. Cytoxan [package insert],2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3